CLASS III Drug recall · Reported 26 Jun 2013 · FDA Enforcement Report

Dr. Sheffield's Triple Antibiotic Ointment Bacitracin recalled

Faria Limited is recalling Dr. Sheffield's Triple Antibiotic Ointment Bacitracin, Neomycin Sulfate 5mg, Polymyxin-B, distributed in California, Georgia, Pennsylvania, Washington. The recall was initiated on 28 May 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot # 10301, Exp 05/14 Lot # 10302, Exp 05/14
Quantity recalled105,744 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-604-2013
FDA event ID
65349
Recalling firm
Faria Limited, New London, CT
Classification
Class III
Status
Terminated
Recall initiated
28 May 2013
FDA classified
14 Jun 2013
Reported
26 Jun 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

28 May 2013Recall initiated by company
14 Jun 2013Classified by FDA+17 days
26 Jun 2013Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications: Unable to meet shelf life expiry.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Dr. Sheffield's Triple Antibiotic Ointment Bacitracin 400 units, Neomycin Sulfate 3.5mg, Polymyxin-B Sulfate 5,000 units, First Aid Antibiotic Ointment, Net Wt. 0.33oz (9g)

Where it was distributed

PA, GA, WA, CA

CaliforniaGeorgiaPennsylvaniaWashington

Questions about this recall

Is Dr. Sheffield's Triple Antibiotic Ointment Bacitracin, Neomycin Sulfate 5mg, Polymyxin-B recalled?

Yes. Faria Limited recalled Dr. Sheffield's Triple Antibiotic Ointment Bacitracin, Neomycin Sulfate 5mg, Polymyxin-B on 28 May 2013. The recall is Class III and its status is Terminated. Recall number D-604-2013.

Why was it recalled?

Failed Stability Specifications: Unable to meet shelf life expiry.

Which lots are affected?

Lot # 10301, Exp 05/14 Lot # 10302, Exp 05/14

Where was it sold?

PA, GA, WA, CA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Faria Limited

All 4